Showing 1 - 10 of 36,040
Contemporary asthma management guidelines list inhaled corticosteroids as the preferred controller medication for … patients with persistent asthma. Despite the availability of explicit guidelines, there is evidence that these agents are … for the treatment of asthma. Like other agents of its class, its efficacy is backed by extensive clinical data. More …
Persistent link: https://www.econbiz.de/10005404779
) with severe oral steroid-dependent asthma (5 mg/day oral prednisolone and >=800 microg/day inhaled steroid) were enrolled … budesonide to regular oral steroid treatment can help to improve symptoms in patients with severe asthma. Moreover, this is … symptoms in patients with severe asthma. However, it is well established that there are a number of undesirable adverse effects …
Persistent link: https://www.econbiz.de/10005448895
(TM)) with chlorofluorocarbon-beclomethasone dipropionate (CFC-BDP) in patients with chronic stable asthma previously receiving …Objective: To compare the cost effectiveness of hydrofluoroalkane 134a-beclomethasone dipropionate (HFA-BDP; Qvar … CFC-BDP in patients with stable asthma. Setting: International, multicentre study at 57 study sites in the US, UK, The …
Persistent link: https://www.econbiz.de/10005404923
asthma symptoms domain scores relative to budesonide. In patients with persistent asthma symptoms while receiving short …Asthma guidelines recommend an inhaled corticosteroid plus a long-acting inhaled beta2-agonist (beta2-adrenoceptor … agonist) as the preferred maintenance therapy for moderate and severe persistent asthma. Advair(R)/Seretide(R) Diskus(R), also …
Persistent link: https://www.econbiz.de/10005449294
cost effective relative to monotherapy with fluticasone propionate or budesonide. Although the total cost of asthma …Cost estimates from developed countries indicate that asthma accounts for up to 2% of the economic cost of all diseases …. A large proportion of asthma-related costs are attributable to poor asthma control. Treatment strategies which improve …
Persistent link: https://www.econbiz.de/10005590268
-group, multicentre trial conducted in Germany, patients with asthma received budesonide/formoterol 160mug/4.5mug in a single inhaler …Objectives: To compare the costs and effectiveness of adjustable maintenance dosing with budesonide/formoterol in a … single inhaler versus fixed dosing in adults with asthma. Methods: In this prospective, randomised, open-label, parallel …
Persistent link: https://www.econbiz.de/10005590301
-care setting - of leukotriene receptor antagonists (LTRAs) as an alternative to inhaled corticosteroids (ICS) for initial asthma … asthma controller therapy. Abstract: Methods:Methods: An economic evaluation was conducted alongside a 2-year, pragmatic …, randomized controlled trial set in 53 primary-care practices in the UK. Patients aged 12-80 years with asthma and symptoms …
Persistent link: https://www.econbiz.de/10008505444
In an effort to improve patient outcomes and reduce resource use and costs associated with asthma care, asthma disease … should be developed in the design phase of the programme. The best practice model for asthma care incorporates a … multidisciplinary approach, using asthma care specialists, case managers, primary care physicians and nurse educators to target `high …
Persistent link: https://www.econbiz.de/10005243027
Asthma is a chronic inflammatory disorder of the airways, affecting about 10% of children and 5 to 7% of the adult … population. Improved asthma control will not only benefit the patient but will also result in reduced financial expenditure in … asthma healthcare. This article summarises the tools that are available for assessing asthma and attempts to quantify the …
Persistent link: https://www.econbiz.de/10005243039
Persistent link: https://www.econbiz.de/10005243090